Back to User profile » Dr Hong Tang
Papers published by Dr Hong Tang:
Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
Tang H, Wang HY, Xi SY, He CY, Chang YX, Wang QM, Wu YF
OncoTargets and Therapy 2018, 11:2557-2563
Published Date: 7 May 2018
PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review
Yang L, Wu Y, Tang H, Zhao J, Zhao D, Yang S, Wang Q
OncoTargets and Therapy 2018, 11:1921-1927
Published Date: 5 April 2018
Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients
Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:2553-2560
Published Date: 15 May 2017
Reduction of AZGP1 predicts poor prognosis in esophageal squamous cell carcinoma patients in Northern China
Tang H, Wu Y, Qin Y, Wang H, Wang L, Guan X, Luo S, Wang Q
OncoTargets and Therapy 2017, 10:85-94
Published Date: 20 December 2016
The coexpression and prognostic significance of c-MET, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study
Jia YX, Li TF, Zhang DD, Fan ZM, Fan HJ, Yan J, Chen LJ, Tang H, Qin YR, Li XY
OncoTargets and Therapy 2016, 9:5919-5929
Published Date: 27 September 2016